Tom Staab | CFO |
Jon Stonehouse | CEO |
Dr. Bill Sheridan | Chief Medical Officer |
Lynne Powell | Chief Commercial Officer |
Jessica Fye | JP Morgan |
Brian Abrahams | RBC Capital Markets |
Maury Raycroft | Jefferies |
Gena Wang | Barclays |
Serge Belanger | Needham and Company |
Good day, ladies and gentlemen. And welcome to the BioCryst Pharmaceuticals Second Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this call is being recorded.